3Q 2025 Earnings Review November 3, 2025 DISCLAIMERS Forward-Looking Statements Certain statements made in this press release are "forward looking statements" within the meaning of the "safe harbor" provisions of the United States Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, Super Group's intention to pay a dividend, including the expected timing of such dividend, expectations and projections of market opportunity, growth and profitabili ...

Greenfire Resources Announces Third Quarter 2025 Results, Operational Update, 2026 Guidance, and Refinancing InitiativesNovember 03, 2025 9:10 PM EST | Source: Greenfire Resources Ltd.Readers are advised to review the "Non-GAAP and Other Financial Measures" section of this press release for information regarding the presentation of financial measures that do not have standardized meaning under IFRS® Accounting Standards. Readers are also advised to review the "Forward-Looking Information" sect ...

Third Quarter 2025 Highlights*: Consolidated Net sales increased 25% Earnings improvements across both segmentsSolutions achieves another record quarter with Net sales and earnings growth of over 30%Paid $0.295 per share cash dividend on September 30, 2025Announced acquisition of Venco Venturo - highly-regarded provider of truck-mounted service cranes and dump hoists*All comparisons are to third quarter 2024 financials, which included one-time gain of approximately $42.3 million from the sale leaseback tran ...

November 3, 2025 Q3 2025 Earnings Conference Call Patients can't wait for the next breakthrough in medical research. So neither will we. Doug Ingram CEO Louise Rodino-Klapac, PhD President, R&D and Technical Operations Patrick E. Moss, PharmD Executive Vice President, Chief Commercial Officer Ryan H. Wong Executive Vice President, Chief Financial Officer DILLON Living with Duchenne muscular dystrophy ©SAREPTA THERAPEUTICS, INC. 2025. ALL RIGHTS RESERVED. 1 Forward-looking statements In order to provide Sare ...

NEWBURYPORT, Mass., Nov. 03, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today reported net income of $16.4 million or $2.11 per diluted common share outstanding for its third quarter ended September 30, 2025, the same as in Q3 of 2024. Adjusted earnings per diluted share outstanding for the third quarter ended September 30, 2025, was $2.39. Sales for the third quarter ...

Freshpet uses certain non-GAAP financial measures, including EBITDA, adjusted EBITDA, adjusted EBITDA as a % of net sales (adjusted EBITDA Margin), adjusted Gross Profit, adjusted Gross Profit Q3 2025 Earnings November 3, 2025 Q3 2025 Earnings Presentation 1 Forward Looking Statements & Non-GAAP Measures FORWARD-LOOKING STATEMENTS Certain statements in this presentation by Freshpet, Inc. (the "Company") constitute "forward-looking" statements within the meaning of the Private Securities Litigation Reform Ac ...

Business Combination with Husky Technologies November 3, 2025 In this presentation, CompoSecure relies on and refers to information and statistics regarding market shares in the sectors in which CompoSecure and/or Husky compete and other industry data. CompoSecure obtained such information and statistics from third-party sources, including reports by market research firms. CompoSecure has supplemented this information where necessary with information from discussions with its and CompoSecure's own internal ...

INVESTOR PRESENTATION November 2025 2025 Q3 Legal Disclaimers Forward Looking Statements and Risk Factors. The information presented herein is generally available from public sources, including our and our subsidiaries' earnings releases and SEC filings. We urge you to read those documents, and we specifically direct you to the forward-looking statements disclaimers and risk factors they contain. The primary purpose of this presentation is to help you understand how we view our Company and our subsidiaries, ...

业绩总结 - MasTec Inc. 第三季度2025年收入为40亿美元，同比增长22%，较指导预期高出2%[5] - 调整后EBITDA为3.73亿美元，同比增长20%，较指导预期高出1%[5] - 调整后稀释每股收益为2.48美元，较去年同期的1.68美元增长47%，超出指导预期0.20美元[5] - 总积压订单为168亿美元，较去年增长21%，环比增长2%[13] - 预计2025年全年的收入指导为140.75亿美元[20] 用户数据与未来展望 - 预计2025年全年的现金流将约为7亿至7.5亿美元[29] - 2025年调整后净收入预计为5.24亿美元，调整后稀释每股收益为6.40美元[20] - 2025年第二半年的调整后EBITDA预计为11.35亿美元[20] - 2024年净收入为1.994亿美元，2025年预计净收入为3.99亿美元，净利率为2.8%[33] - 2024年第三季度净收入为1.054亿美元，2025年第三季度预计净收入为1.665亿美元，净利率为4.2%[39] 财务指标 - 2024年EBITDA为9.508亿美元，EBITDA利润率为7.7%；2025年预计EBITDA为11亿美元，EBITDA利润率为7.8%[33] - 2024年第三季度EBITDA为2.986亿美元，EBITDA利润率为9.2%；2025年第三季度预计EBITDA为3.616亿美元，EBITDA利润率为9.1%[39] - 截至2024年9月30日的总债务为23.238亿美元，较2025年6月30日的22.574亿美元上升了2.9%[50] - 截至2024年9月30日的净债务为21.426亿美元，较2025年6月30日的21.255亿美元上升了0.8%[50] - 截至2024年9月30日的杠杆率为2.2倍，较2025年6月30日的2.0倍上升了10%[50] 其他财务信息 - 截至2024年9月30日的利息支出为2.094亿美元，较2025年6月30日的1.735亿美元上升了20.8%[50] - 截至2024年9月30日的折旧费用为3.984亿美元，较2025年6月30日的3.033亿美元上升了31.4%[50] - 截至2024年9月30日的无形资产摊销费用为1.447亿美元，较2025年6月30日的1.379亿美元上升了4.9%[50] - 截至2024年9月30日的所得税准备金为3.860亿美元，较2025年6月30日的7.060亿美元下降了45.4%[50]

October 31, 2025 Q3 2025 Results Stephan B. Tanda, Aptar President and CEO Vanessa Kanu, Executive Vice President and CFO Forward Looking Statements & Non-GAAP Financial Measures This presentation includes forward-looking statements. Forward-looking statements are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 and are based on management's beliefs and assumptions in light of information currently available to ma ...